SCHEMBL8029969

SCHEMBL8029969

CC1C2=C(O[C@@H]1C)c1ccccc1C(=O)C2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 5/20 0.41
LMNA P02545 4/20 0.41
BLM P54132 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
RAB9A P51151 4/20 0.41
MAPK1 P28482 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 3/20 0.41
PTPRC P08575 2/20 0.41
CES2 O00748 2/20 0.41
TDP2 O95551 2/20 0.41
THRB P10828 2/20 0.41
CES1 P23141 2/20 0.41
RECQL P46063 2/20 0.41
PLIN1 O60240 2/20 0.41
MAOA P21397 2/20 0.41
PLIN5 Q00G26 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14439353 1.00 MEN1 (0.41) MEN1KMT2AMAPTLMNABLM
SCHEMBL5940376 1.00 MEN1 (0.41) MEN1KMT2AMAPTLMNABLM
SCHEMBL5940374 1.00 MEN1 (0.41) MEN1KMT2AMAPTLMNABLM
SCHEMBL8260617 0.85 IDO1 (0.35) MEN1KMT2AMAPTLMNABLM
SCHEMBL16298303 0.83 MEN1 (0.39) MEN1KMT2AMAPTLMNABLM
SCHEMBL5940203 0.80 IDO1 (0.37) MEN1KMT2AMAPTLMNABLM
SCHEMBL25704049 0.72 EPHX2 (0.38) MEN1KMT2ASMN1; SMN2RAB9APOLB
SCHEMBL25704048 0.70 IDO1 (0.37) MEN1KMT2AMAPTLMNABLM
SCHEMBL15256933 0.69 ALDH1A1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL103949 0.69 IDO1 (0.53) MEN1KMT2AMAPTLMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009084834-A2 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE MAZENCE INC. (KR) 2009-07-09 WO disclosed
WO-2009082124-A2 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GLAUCOMA MAZENCE INC. (KR) 2009-07-02 WO disclosed